Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2000 1
2001 4
2003 1
2004 1
2008 1
2014 6
2015 14
2016 9
2017 4
2018 6
2019 8
2020 24
2021 22
2022 27
2023 20
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

148 results

Results by year

Filters applied: . Clear all
Page 1
Parasitic infections related to anti-type 2 immunity monoclonal antibodies: a disproportionality analysis in the food and drug administration's adverse event reporting system (FAERS).
Pera V, Brusselle GG, Riemann S, Kors JA, Van Mulligen EM, Parry R, de Wilde M, Rijnbeek PR, Verhamme KMC. Pera V, et al. Among authors: rijnbeek pr. Front Pharmacol. 2023 Nov 14;14:1276340. doi: 10.3389/fphar.2023.1276340. eCollection 2023. Front Pharmacol. 2023. PMID: 38035014 Free PMC article.
Real-world treatment trajectories of adults with newly diagnosed asthma or COPD.
Markus AF, Rijnbeek PR, Kors JA, Burn E, Duarte-Salles T, Haug M, Kim C, Kolde R, Lee Y, Park HS, Park RW, Prieto-Alhambra D, Reyes C, Krishnan JA, Brusselle GG, Verhamme KM. Markus AF, et al. Among authors: rijnbeek pr. BMJ Open Respir Res. 2024 Feb 27;11(1):e002127. doi: 10.1136/bmjresp-2023-002127. BMJ Open Respir Res. 2024. PMID: 38413124 Free PMC article.
Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study.
Li X, Ostropolets A, Makadia R, Shoaibi A, Rao G, Sena AG, Martinez-Hernandez E, Delmestri A, Verhamme K, Rijnbeek PR, Duarte-Salles T, Suchard MA, Ryan PB, Hripcsak G, Prieto-Alhambra D. Li X, et al. Among authors: rijnbeek pr. BMJ. 2021 Jun 14;373:n1435. doi: 10.1136/bmj.n1435. BMJ. 2021. PMID: 35727911 Free PMC article.
Predictive approaches to heterogeneous treatment effects: a scoping review.
Rekkas A, Paulus JK, Raman G, Wong JB, Steyerberg EW, Rijnbeek PR, Kent DM, van Klaveren D. Rekkas A, et al. Among authors: rijnbeek pr. BMC Med Res Methodol. 2020 Oct 23;20(1):264. doi: 10.1186/s12874-020-01145-1. BMC Med Res Methodol. 2020. PMID: 33096986 Free PMC article. Review.
Pharmacogenetics of Drug-Induced QT Interval Prolongation: An Update.
Niemeijer MN, van den Berg ME, Eijgelsheim M, Rijnbeek PR, Stricker BH. Niemeijer MN, et al. Among authors: rijnbeek pr. Drug Saf. 2015 Oct;38(10):855-67. doi: 10.1007/s40264-015-0316-6. Drug Saf. 2015. PMID: 26108299 Free PMC article. Review.
Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study.
Voss EA, Shoaibi A, Yin Hui Lai L, Blacketer C, Alshammari T, Makadia R, Haynes K, Sena AG, Rao G, van Sandijk S, Fraboulet C, Boyer L, Le Carrour T, Horban S, Morales DR, Martínez Roldán J, Ramírez-Anguita JM, Mayer MA, de Wilde M, John LH, Duarte-Salles T, Roel E, Pistillo A, Kolde R, Maljković F, Denaxas S, Papez V, Kahn MG, Natarajan K, Reich C, Secora A, Minty EP, Shah NH, Posada JD, Garcia Morales MT, Bosca D, Cadenas Juanino H, Diaz Holgado A, Pedrera Jiménez M, Serrano Balazote P, García Barrio N, Şen S, Üresin AY, Erdogan B, Belmans L, Byttebier G, Malbrain MLNG, Dedman DJ, Cuccu Z, Vashisht R, Butte AJ, Patel A, Dahm L, Han C, Bu F, Arshad F, Ostropolets A, Nyberg F, Hripcsak G, Suchard MA, Prieto-Alhambra D, Rijnbeek PR, Schuemie MJ, Ryan PB. Voss EA, et al. Among authors: rijnbeek pr. EClinicalMedicine. 2023 Apr;58:101932. doi: 10.1016/j.eclinm.2023.101932. Epub 2023 Apr 4. EClinicalMedicine. 2023. PMID: 37034358 Free PMC article.
Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study.
Gauffin O, Brand JS, Vidlin SH, Sartori D, Asikainen S, Català M, Chalabi E, Dedman D, Danilovic A, Duarte-Salles T, García Morales MT, Hiltunen S, Jödicke AM, Lazarevic M, Mayer MA, Miladinovic J, Mitchell J, Pistillo A, Ramírez-Anguita JM, Reyes C, Rudolph A, Sandberg L, Savage R, Schuemie M, Spasic D, Trinh NTH, Veljkovic N, Vujovic A, de Wilde M, Zekarias A, Rijnbeek P, Ryan P, Prieto-Alhambra D, Norén GN. Gauffin O, et al. Among authors: rijnbeek p. Drug Saf. 2023 Dec;46(12):1335-1352. doi: 10.1007/s40264-023-01353-w. Epub 2023 Oct 7. Drug Saf. 2023. PMID: 37804398 Free PMC article.
148 results